No Result
View All Result
China Secrets Revealed
  • Economy
  • Editor’s Pick
  • Investing
  • News
  • Stock
  • Economy
  • Editor’s Pick
  • Investing
  • News
  • Stock
No Result
View All Result
China Secrets Revealed
No Result
View All Result
Home Investing

Coursera-Udemy deal: why regulatory approval may not be a breeze

by
December 17, 2025
in Investing
0
Coursera-Udemy deal: why regulatory approval may not be a breeze

Coursera’s (NYSE: COUR) proposed all-stock acquisition of Udemy (UDMY) has laid the groundwork for one of the largest consolidations the ed-tech sector has seen in years.

The deal, valued at about $2.5 billion, will combine two of the most recognizable US-based online learning platforms at a time when the industry is shifting toward AI-driven workforce training.

Udemy stock opened nearly 30% higher on the COUR news today – but is reversing some of those gains at writing as investors weigh the likelihood of prolonged regulatory review.

The price action reflects a clear stance: the merger, they believe, is attractive on paper, but far from guaranteed a smooth antitrust approval.

Why Coursera-Udemy deal may not sit well with regulators

Securing regulatory approval for the Udemy deal is unlikely to be a “breeze” for Coursera because they are two of the largest US-based MOOC and workforce-training platforms.

Over the past two years, both have aggressively repositioned themselves toward enterprise clients seeking artificial intelligence skills development.  

This is no longer a niche segment – it has become a strategically important market for governments and regulators who view artificial intelligence literacy as a national competitiveness issue.

A transaction that consolidates two major players in this space could raise concerns about pricing power, access to training content, and the ability of smaller platforms to compete.

What else could delay Coursera-Udemy deal approval?

One of the most sensitive aspects of the Coursera-Udemy deal is how the combined company will manage the vast amount of data generated from enterprise learners.

Both platforms rely on AI-driven personalization to tailor course recommendations, assessments, and skill-development pathways.

Therefore, regulators will likely probe whether the merged entity will gain disproportionate control over valuable workforce-training data.

Concerns may also extend to how algorithms are trained, how learner information is stored, and whether smaller competitors will be disadvantaged by limited access to comparable datasets.

Because the deal sits at the intersection of AI, data privacy, and labour‑market development, this issue alone could slow approval or trigger demands for strict behavioural commitments.

Antitrust authorities no longer favour tech consolidation

The regulatory environment in 2025-26 is markedly more skeptical of tech consolidation than in previous cycles.

Both US and EU authorities have signalled a willingness to challenge mergers that fall into gray areas, even when they do not present obvious antitrust violations.

Data privacy, AI‑training models, and cross‑border information flows are now central to regulatory reviews, and the Coursera-Udemy deal intersects with all three.

Therefore, the US antitrust authorities may demand detailed commitments around data handling, algorithmic transparency, and instructor-platform relationships.

All in all, even if the deal ultimately clears, it’s unlikely to do so quickly or without concessions.

The current political climate simply doesn’t favour fast approval for large tech-adjacent mergers, and this deal won’t be an exception.

The post Coursera-Udemy deal: why regulatory approval may not be a breeze appeared first on Invezz

Previous Post

Why Jefferies, Morgan Stanley raised Apple stock price targets

Next Post

Senate sends $901B defense bill to Trump after clashes over boat strike, DC airspace

Next Post
Senate sends $901B defense bill to Trump after clashes over boat strike, DC airspace

Senate sends $901B defense bill to Trump after clashes over boat strike, DC airspace

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!
  • Trending
  • Comments
  • Latest
ALEX BERENSON: Trump’s marijuana order pushes a dangerous lie about drugs

ALEX BERENSON: Trump’s marijuana order pushes a dangerous lie about drugs

0
TD Cowen downgrades Molson Coors, lowers price target to $58: Is it time to exit?

TD Cowen downgrades Molson Coors, lowers price target to $58: Is it time to exit?

0
Google’s antitrust ruling draws parallels to Microsoft’s 25-year-old case: Here’s how

Google’s antitrust ruling draws parallels to Microsoft’s 25-year-old case: Here’s how

0
In 2023, Colorado Lawmakers Pushed Back on Cops Practicing Pain Medicine Based on Flawed CDC Guideline

In 2023, Colorado Lawmakers Pushed Back on Cops Practicing Pain Medicine Based on Flawed CDC Guideline

0
ALEX BERENSON: Trump’s marijuana order pushes a dangerous lie about drugs

ALEX BERENSON: Trump’s marijuana order pushes a dangerous lie about drugs

December 20, 2025
Conservative legal group sounds alarm over CDC tool, reveals why Trump admin should eliminate race

Conservative legal group sounds alarm over CDC tool, reveals why Trump admin should eliminate race

December 19, 2025
Trump takes axe to federal red tape, cuts 600+ rules in one year, touts billions in savings

Trump takes axe to federal red tape, cuts 600+ rules in one year, touts billions in savings

December 19, 2025
Trump administration targets Maduro’s inner circle, family in major narco-state crackdown

Trump administration targets Maduro’s inner circle, family in major narco-state crackdown

December 19, 2025

Recent News

ALEX BERENSON: Trump’s marijuana order pushes a dangerous lie about drugs

ALEX BERENSON: Trump’s marijuana order pushes a dangerous lie about drugs

December 20, 2025
Conservative legal group sounds alarm over CDC tool, reveals why Trump admin should eliminate race

Conservative legal group sounds alarm over CDC tool, reveals why Trump admin should eliminate race

December 19, 2025
Trump takes axe to federal red tape, cuts 600+ rules in one year, touts billions in savings

Trump takes axe to federal red tape, cuts 600+ rules in one year, touts billions in savings

December 19, 2025
Trump administration targets Maduro’s inner circle, family in major narco-state crackdown

Trump administration targets Maduro’s inner circle, family in major narco-state crackdown

December 19, 2025

Disclaimer: ChinaSecretsRevealed.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2024 ChinaSecretsRevealed. All Rights Reserved.

No Result
View All Result
  • Economy
  • Editor’s Pick
  • Investing
  • News
  • Stock

Copyright © 2024 ChinaSecretsRevealed. All Rights Reserved.